1,046 results on '"Wei, Yu-Quan"'
Search Results
52. The Promotion of Erythropoiesis via the Regulation of Reactive Oxygen Species by Lactic Acid
53. (Z)-5-(4-methoxybenzylidene)thiazolidine-2,4-dione attenuates bleomycin-induced pulmonary fibrosis in rats
54. Phosphatidylserine released from apoptotic cells in tumor induces M2‐like macrophage polarization through the PSR‐STAT3‐JMJD3 axis
55. Accumulation of FLT3+ CD11c+ dendritic cells in psoriatic lesions and the anti-psoriatic effect of a selective FLT3 inhibitor
56. Mannan-modified adenovirus encoding VEGFR-2 as a vaccine to induce anti-tumor immunity
57. Synergic antitumor effect of SKLB1002 and local hyperthermia in 4T1 and CT26
58. Development of PLGA Nanoparticles Simultaneously Loaded with Vincristine and Verapamil for Treatment of Hepatocellular Carcinoma
59. An integrated scheme for feature selection and parameter setting in the support vector machine modeling and its application to the prediction of pharmacokinetic properties of drugs
60. Synthesis and characterization of biodegradable pH-sensitive hydrogels based on poly(ɛ-caprolactone), methacrylic acid, and poly(ethylene glycol)
61. Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles
62. Support vector machine and pharmacophore-based prediction models of multidrug-resistance protein 2 (MRP2) inhibitors
63. A preclinical evaluation of a novel multikinase inhibitor, SKLB-329, as a therapeutic agent against hepatocellular carcinoma
64. hPNAS-4 inhibits proliferation through S phase arrest and apoptosis: underlying action mechanism in ovarian cancer cells
65. Cancer Microenvironment and Cancer Vaccine
66. In vitro and in vivo anti-tumor activities of anti-EGFR single-chain variable fragment fused with recombinant gelonin toxin
67. The p53 Upregulated Modulator of Apoptosis (PUMA) Chemosensitizes Intrinsically Resistant Ovarian Cancer Cells to Cisplatin by Lowering the Threshold Set by Bcl-xL and Mcl-1
68. Effect of training data size and noise level on support vector machines virtual screening of genotoxic compounds from large compound libraries
69. Polyclonal rabbit anti-murine plasmacytoma cell globulins induce myeloma cells apoptosis and inhibit tumour growth in mice
70. Therapeutic effects of survivin dominant negative mutant in a mouse model of prostate cancer
71. Simultaneous quantitation of aconitine, mesaconitine, hypaconitine, benzoylaconine, benzoylmesaconine and benzoylhypaconine in human plasma by liquid chromatography–tandem mass spectrometry and pharmacokinetics evaluation of “SHEN-FU” injectable powder
72. Towards more accurate pharmacophore modeling: Multicomplex-based comprehensive pharmacophore map and most-frequent-feature pharmacophore model of CDK2
73. Prediction models of human plasma protein binding rate and oral bioavailability derived by using GA–CG–SVM method
74. Antitumor effect of mSurvivinThr34 → Ala in murine colon carcinoma when administered intravenously
75. Suppression of human MDA-MB-435S tumor by U6 promoter-driven short hairpin RNAs targeting focal adhesion kinase
76. MicroRNA-17 post-transcriptionally regulates polycystic kidney disease-2 gene and promotes cell proliferation
77. Down-regulation of Pkd2 by siRNAs suppresses cell–cell adhesion in the mouse melanoma cells
78. Low-dose paclitaxel improves the therapeutic efficacy of recombinant adenovirus encoding CCL21 chemokine against murine cancer
79. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin
80. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK
81. Therapeutic effects of recombinant human endostatin adenovirus in a mouse model of malignant pleural effusion
82. Therapeutic target database update 2014: a resource for targeted therapeutics
83. Antitumor and Adjuvant Activity of λ-carrageenan by Stimulating Immune Response in Cancer Immunotherapy
84. Comparative plasma membrane-associated proteomics of immortalized human hepatocytes
85. Vesicular stomatitis virus matrix protein gene enhances the antitumor effects of radiation via induction of apoptosis
86. Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer
87. Preparation and characterization of honokiol nanoparticles
88. Synergistic antitumor effect of CXCL10 with hyperthermia
89. SARS-CoV-2 M pro inhibitors with antiviral activity in a transgenic mouse model
90. Different attitudes of oncology clinicians toward truth telling of different stages of cancer
91. Human T lymphocyte responses against lung cancer induced by recombinant truncated mouse EGFR
92. Combined effects of soluble vascular endothelial growth factor receptor FLT-1 gene therapy and cisplatin chemotherapy in human tongue carcinoma xenografts
93. Armed T cells with CAR for cancer immunotherapy
94. Cancer Biotherapy
95. List of Contributors
96. Enhanced antitumor efficacy by blocking activation of the phosphatidylinositol 3-kinase/Akt pathway during anti-angiogenesis therapy
97. Improved solubility and pharmacokinetics of PEGylated liposomal honokiol and human plasma protein binding ability of honokiol
98. Hyperprogression: A novel response pattern under immunotherapy
99. Progress in Neoantigen Targeted Cancer Immunotherapies
100. Enhancement of the antitumor effect of HER2‐directed CAR‐T cells through blocking epithelial‐mesenchymal transition in tumor cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.